Yokohama, Japan

Yoshikuno Tamao


Average Co-Inventor Count = 6.3

ph-index = 6

Forward Citations = 79(Granted Patents)


Location History:

  • Yokohama, JA (1978)
  • Yokohama, JP (1978 - 1979)

Company Filing History:


Years Active: 1978-1979

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of Yoshikuno Tamao

Introduction

Yoshikuno Tamao is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit thrombosis. With a total of 10 patents to his name, his work has had a considerable impact on medical science.

Latest Patents

Tamao's latest patents include N²-Naphthalenesulfonyl-L-arginine derivatives and N²-naphthalenesulfonyl-L-arginine amides. These compounds are characterized by their complex chemical structures, which include various substituents that enhance their pharmaceutical efficacy. The derivatives and amides have been found to be effective as pharmaceutical agents for the inhibition and suppression of thrombosis, showcasing their potential in medical applications.

Career Highlights

Throughout his career, Yoshikuno Tamao has worked with notable companies, including Mitsubishi Chemical Industries Limited. His experience in the industry has allowed him to develop innovative solutions that address critical health issues. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Tamao has collaborated with esteemed colleagues such as Shosuke Okamoto and Ryoji Kikumoto. These partnerships have fostered an environment of innovation and have contributed to the advancement of their shared research goals.

Conclusion

Yoshikuno Tamao's contributions to pharmaceutical science through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the development of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…